1. Volume 144, Issue 7, Pages 1450-1455.e2 (June 2013)
Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies 
Jianmeng Chen, Jeffry Florian, Wendy Carter, Russell D. Fleischer, Thomas S. Hammerstrom, Pravin R. Jadhav, Wen Zeng, Jeffrey Murray, Debra Birnkrant 
Gastroenterology 
Volume 144, Issue 7, Pages e2 (June 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
SVR12 and SVR24 measurements from 15 CHC trials submitted to the Agency over 2002–2011. These trials include treatment arms of various durations with interferon, pegylated interferon (PegIFN) with and without ribavirin (P/R), DAA with P/R, and regimens with and without response-guided therapy.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions